UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Synthetic cytokine circuits that drive T cells into immune-excluded tumors

Science (American Association for the Advancement of Science), 2022-12, Vol.378 (6625), p.eaba1624

2022

Volltextzugriff (PDF)

Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study–Renal (CANVAS‐R): A randomized, placebo‐controlled trial

Diabetes, obesity & metabolism, 2017-03, Vol.19 (3), p.387-393

2017

Volltextzugriff (PDF)

Efficacy and safety of canagliflozin by baseline HbA1c and known duration of type 2 diabetes mellitus

Journal of diabetes and its complications, 2015-04, Vol.29 (3), p.438-444

2015

Volltextzugriff (PDF)

528 Activated T cells engage IL-1 and TNFa-driven tumor inflammation to support immune checkpoint inhibitor resistance in inflammatory solid malignancies

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A600-A600

2023

Volltextzugriff (PDF)

Canagliflozin Compared With Sitagliptin for Patients With Type 2 Diabetes Who Do Not Have Adequate Glycemic Control With Metformin Plus Sulfonylurea: A 52-week randomized trial

Diabetes care, 2013-09, Vol.36 (9), p.2508-2515

2013

Volltextzugriff (PDF)

The Nutrition, Aging, and Memory in Elders (NAME) study: design and methods for a study of micronutrients and cognitive function in a homebound elderly population

International journal of geriatric psychiatry, 2006-06, Vol.21 (6), p.519-528

2006

Volltextzugriff (PDF)

Countdown

Canadian Medical Association journal (CMAJ), 2020-02, Vol.192 (8), p.E193-E194

Yee, Amanda Jacqueline

2020

Volltextzugriff (PDF)

Fall Creek Monitoring Station: Using Environmental Covariates To Predict Micropollutant Dynamics and Peak Events in Surface Water Systems

Environmental science & technology, 2019-08, Vol.53 (15), p.8599-8610

2019

Volltextzugriff (PDF)

EFFICACY AND SAFETY OF GUSELKUMAB THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE: RESULTS OF THE GALAXI 2 & 3 PHASE 3 STUDIES

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.1057b,1057b1,1057b2-1057b,1057b1,1057b2

2024

Volltextzugriff (PDF)

Efficacy and safety of canagliflozin in patients with type 2 diabetes based on history of cardiovascular disease or cardiovascular risk factors: a post hoc analysis of pooled data

Cardiovascular diabetology, 2017-03, Vol.16 (1), p.40-40, Article 40

2017

Volltextzugriff (PDF)

Synthetic cytokine circuits that drive T cell infiltration into immune-excluded tumors

Science (American Association for the Advancement of Science), 2022-12, Vol.378 (6625), p.eaba1624-eaba1624

2022

Volltextzugriff (PDF)

Abstract 12482: Efficacy and Safety of Canagliflozin in Patients With Type 2 Diabetes Based on History of Cardiovascular Disease or Cardiovascular Risk Factors

Circulation (New York, N.Y.), 2016-11, Vol.134 (Suppl_1 Suppl 1), p.A12482-A12482

2016

Volltextzugriff (PDF)

The SAGES telephone neuropsychological battery: correlation with in‐person measures

International journal of geriatric psychiatry, 2017-09, Vol.32 (9), p.991-999

2017

Volltextzugriff (PDF)

Abstract 557: Blood-Pressure Lowering Effects of Canagliflozin Across a Range of Background Antihyperglycemic Treatment Regimens Used in Patients with Type 2 Diabetes Mellitus

Hypertension (Dallas, Tex. 1979), 2014-09, Vol.64 (suppl_1)

2014

Volltextzugriff (PDF)

Acute pancreatitis risk in type 2 diabetes patients treated with canagliflozin versus other antihyperglycemic agents: an observational claims database study

Current medical research and opinion, 2020-07, Vol.36 (7), p.1117-1124

2020

Volltextzugriff (PDF)

Achievement of treatment goals with canagliflozin in patients with type 2 diabetes mellitus: a pooled analysis of randomized controlled trials

Current medical research and opinion, 2015-11, Vol.31 (11), p.1993-2000

2015

Volltextzugriff (PDF)

1546-P: Acute Pancreatitis (AP) with Canagliflozin (CANA) vs. Other Antihyperglycemic Agents (AHAs): An Observational Study

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

EFFICACY AND SAFETY OF CANAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES BASED ON HISTORY OF CARDIOVASCULAR DISEASE OR CARDIOVASCULAR RISK FACTORS

Endocrine practice, 2017-01, Vol.23 (1), p.14A

2017

Volltextzugriff (PDF)

Perianal keratoacanthoma in a 76‐year‐old man

ANZ journal of surgery, 2021-07, Vol.91 (7-8), p.E542-E543

2021

Volltextzugriff (PDF)

Mycological isolation from animal enclosures and environments in National Wildlife Rescue Centre and National Zoo, Malaysia

Journal of Veterinary Medical Science, 2020, pp.20-0229

2020

Volltextzugriff (PDF)

Canagliflozin Compared With Sitagliptin for Patients With Type 2 Diabetes Who Do Not Have Adequate Glycemic Control With Metformin Plus Sulfonylurea

Diabetes care, 2013-09, Vol.36 (9), p.2508-2515

2013

Volltextzugriff (PDF)

Efficacy and safety of canagliflozin by baseline HbA1cand known duration of type 2 diabetes mellitus

Journal of diabetes and its complications, 2015-04, Vol.29 (3), p.438

2015

Volltextzugriff (PDF)

Virtual Technology (VR) Attractiveness Attributes in Influencing House Buyers’ Intention to Purchase

Journal of Advanced Research in Applied Sciences and Engineering Technology, 2023-01, Vol.29 (2), p.126-134

2023

Volltextzugriff (PDF)

Depression, Antidepressants, and Plasma Amyloid β (Beta) Peptides in Those Elderly Who Do Not Have Cardiovascular Disease

Biological psychiatry (1969), 2007-12, Vol.62 (12), p.1413-1417

2007

Volltextzugriff (PDF)

1 – 25 von 269

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(230)
Mit Volltextzugriff
(217)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(269)
Japanisch
(20)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Dynamic CD8+ T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes

Synthetic cytokine circuits that drive T cells into immune-excluded tumors

Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study–Renal (CANVAS‐R): A randomized, placebo‐controlled trial

Efficacy and safety of canagliflozin by baseline HbA1c and known duration of type 2 diabetes mellitus

528 Activated T cells engage IL-1 and TNFa-driven tumor inflammation to support immune checkpoint inhibitor resistance in inflammatory solid malignancies

Canagliflozin Compared With Sitagliptin for Patients With Type 2 Diabetes Who Do Not Have Adequate Glycemic Control With Metformin Plus Sulfonylurea: A 52-week randomized trial

The Nutrition, Aging, and Memory in Elders (NAME) study: design and methods for a study of micronutrients and cognitive function in a homebound elderly population

Countdown

Fall Creek Monitoring Station: Using Environmental Covariates To Predict Micropollutant Dynamics and Peak Events in Surface Water Systems

EFFICACY AND SAFETY OF GUSELKUMAB THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE: RESULTS OF THE GALAXI 2 & 3 PHASE 3 STUDIES

Efficacy and safety of canagliflozin in patients with type 2 diabetes based on history of cardiovascular disease or cardiovascular risk factors: a post hoc analysis of pooled data

Synthetic cytokine circuits that drive T cell infiltration into immune-excluded tumors

Abstract 12482: Efficacy and Safety of Canagliflozin in Patients With Type 2 Diabetes Based on History of Cardiovascular Disease or Cardiovascular Risk Factors

The SAGES telephone neuropsychological battery: correlation with in‐person measures

Abstract 557: Blood-Pressure Lowering Effects of Canagliflozin Across a Range of Background Antihyperglycemic Treatment Regimens Used in Patients with Type 2 Diabetes Mellitus

Acute pancreatitis risk in type 2 diabetes patients treated with canagliflozin versus other antihyperglycemic agents: an observational claims database study

Achievement of treatment goals with canagliflozin in patients with type 2 diabetes mellitus: a pooled analysis of randomized controlled trials

1546-P: Acute Pancreatitis (AP) with Canagliflozin (CANA) vs. Other Antihyperglycemic Agents (AHAs): An Observational Study

EFFICACY AND SAFETY OF CANAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES BASED ON HISTORY OF CARDIOVASCULAR DISEASE OR CARDIOVASCULAR RISK FACTORS

Perianal keratoacanthoma in a 76‐year‐old man

Mycological isolation from animal enclosures and environments in National Wildlife Rescue Centre and National Zoo, Malaysia

Canagliflozin Compared With Sitagliptin for Patients With Type 2 Diabetes Who Do Not Have Adequate Glycemic Control With Metformin Plus Sulfonylurea

Efficacy and safety of canagliflozin by baseline HbA1cand known duration of type 2 diabetes mellitus

Virtual Technology (VR) Attractiveness Attributes in Influencing House Buyers’ Intention to Purchase

Depression, Antidepressants, and Plasma Amyloid β (Beta) Peptides in Those Elderly Who Do Not Have Cardiovascular Disease

Suchergebnisse filtern